Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Red iron oxide stands among the oldest pigments people have ever used, showing up in cave paintings dating back thousands of years. Ancient Egyptians, Greeks, and Romans leaned on its deep red color for cosmetics, wall art, and even healing rituals. Renaissance artists ground this mineral to powder, mixed it with oil, and laid down those rich earthy backgrounds in timeless masterpieces. Over the centuries, demand for cleaner, safer, and more reliable raw materials grew, especially as medicine and science moved from folk remedies to strict regulation. The journey from primitive ochre rock to today’s refined BP, EP, and USP pharma grades charts the world’s move toward precision, evidence, and safety in everything that touches skin, enters a wound, or forms part of a drug delivery system.
Red iron oxide, more formally known as ferric oxide or Fe₂O₃, carries a color many folks recognize from rusty metal or red clay. The pharma grade steps well past the basics, holding itself to strict limits on trace metals, soluble salts, and microbial contamination. BP, EP, and USP standards came about from the big regulatory bodies—the British, European, and United States Pharmacopeias—each mapping out what’s acceptable in medicine and personal care. Red iron oxide in this class pulls double duty. It works as a pigment in tablets, creams, and cosmetics, but it also pops up as an excipient and opacifier, helping things look right and work as intended. The product’s high purity and defined particle sizes cut down on contamination risk, an issue easy to overlook but tough to fix when health is on the line.
Red iron oxide arrives as a fine, brick-red powder. Under a microscope, it shows off tightly-packed crystals that barely reflect light, throwing a matte finish that gives substance to paints and medicines alike. Chemically, it’s Fe₂O₃, with iron held tight by oxygen in a stable bond. This stability keeps it from reacting where it shouldn’t, such as inside a medicine cabinet or on open skin. Unlike many minerals, it shrugs off most acids and alkalis—think lemon juice or pantry vinegar—and won’t melt until things get hotter than a furnace. Pharma versions push for nearly total iron content, low moisture, and absence of pesky heavy metals like lead or mercury. Granules that clump or powders that carry odd smells signal trouble; pure product always falls within a set color range, sieves out clean, and flows almost like dry sand.
Each batch of red iron oxide BP, EP, USP gets trailed by a paper trail a mile long: batch number, assay value, moisture content, and heavy metal analysis. Genuine product always shows a compliance statement for the pharmacopeia it claims, along with shelf life and storage advice. Labels should flag lot numbers and production dates for total traceability in a recall. Labs or pharmaceutical plants want a Certificate of Analysis—anything less is a gamble. Standard tests hunt down arsenic, soluble salts, and other colorants to verify nothing crept in during processing. Particle size matters too, especially for tablets. Get it wrong, and coatings crack or don’t cover. Each listed feature ties directly to safety and effectiveness—an area where a single shortcut can break the entire chain of trust between provider and patient.
Red iron oxide at pharma grade doesn’t come straight from the ground. Start with iron salts, usually iron sulfate or iron chloride, and hit them with heat in an oxidizing environment—either air or a controlled atmosphere. Sometimes water is involved. The process can look simple, but the conditions need fine-tuning so particles end up the right size and purity. Wash the product to pull out unwanted salts and then dry it under controlled temperatures. Any shortcut invites contamination—a batch with impurities could fail at the last quality check. Factories keep everything in closed systems to keep dust out, then seal and pack in dedicated clean rooms. This tight process distinguishes pharma grade from the same-colored powders used for construction or ceramics, where purity matters less.
Ferric oxide stands up to heat and light. Most acids just bounce off, though some strong kinds can break it down over time. It doesn’t dissolve in water, which is a blessing in a lot of pharma applications. Technicians can tweak the surface in several ways—coating the particles with silicates or organics—to help it disperse or blend in oily or watery mediums. In pigment science, chemists sometimes dope the crystals with small amounts of other ions, shifting color slightly or changing how the powder behaves. These modifications change the feel, look, and even bio-compatibility, opening doors beyond color into new drug or material roles.
People in different fields call red iron oxide by different names. Chemists like to say ferric oxide or iron(III) oxide. The paint world calls it red ochre or iron red. On medicine labels, pharmaceutical red iron oxide BP, EP, or USP shows up as CI 77491, a code that guarantees strict standards. Other terms, like rouge, once meant the fine powder used for polishing jewelry and skin, now largely replaced by other materials as standards shifted. No matter the name, the high-purity material always shows its compliance and traceable source.
Handling red iron oxide in pharmaceutical settings means following some strict rules. Lab coats, gloves, and dust masks block powder inhalation. Workers need ventilated stations to avoid breathing in particles, which, over long periods, can lead to industrial illness. Transport and storage call for dry, clean containers, away from acids or organics that might react with the mineral. Regulatory bodies audit supply chains, monitor for trace toxins, and require full documentation from mine to medicine bottle. The finished powder won’t fuel a fire or spark a chemical chain reaction, making it safer than many lab chemicals. But slack routines—like letting powder settle on surfaces or skipping a final screen—can build risk up quickly, especially on shared production lines.
Pharmaceutical grade red iron oxide’s deep color lets drug makers control appearance and ID, especially in coated tablets where quick visual recognition speeds up dispensing and cuts down errors. In creams and lotions, it gives a warm tint without causing allergies or reactions that some synthetic colors bring. Toothpastes, sunscreens, and ointments use it for its stability and because the body doesn’t absorb it in dangerous amounts. Dental products often favor it for safe account of its long-established record. Beyond health, some foods sport minuscule quantities of certified red iron oxide for looks—though this use stays rare due to stricter food additive regulations. Its non-reactive nature and track record of safety make it a go-to pigment and excipient across medicine and care products.
Ongoing lab work keeps pushing red iron oxide beyond its old role as pigment. Universities and pharma labs explore nano-sized particles for advanced drug delivery, hoping to use the oxide’s surface traits to carry drugs right where they’re needed while avoiding healthy tissue. Some experiments link red iron oxide to magnetic tracking or heating, opening up new doors in cancer therapy and diagnostic imaging. Investments keep ramping up around how to tweak the oxide’s structure or blend it with polymers to smooth out controlled drug release or protect delicate molecules from heat, moisture, or UV light during storage or delivery. Every published study in this field ties back into questions of safety, effectiveness, and cost—nobody wants the next wonder powder if supply chains can’t guarantee purity or a stable price.
Red iron oxide carries a long history as a pigment, but scientists have not left safety to old records alone. Animal studies and occupational health surveys show that the mineral isn’t absorbed well through the skin or gut. Too much inhaled dust can trigger lung changes or chronic cough for people working daily on powder production lines. Pharmaceutical versions cut those risks through particle sizing and manufacturing controls. Regulatory agencies like the FDA and EMA accept red iron oxide as an indirect additive or pigment based on long-term safety data, although they keep a close eye on potential nano-specific effects and batch purity. Otherwise, the toxic profile stays low, with problems tied more often to process errors than to the mineral itself.
Rapid shifts in medicine, technology, and materials science point toward red iron oxide gaining new uses. As therapies get more personalized and stricter about excipients, demand for clean, traceable, and characterizable pigments will likely keep rising. The next leap may come from biotechnology and nanomedicine, tapping into iron oxide’s stability, surface chemistry, and ability to act as a tiny carrier. Environmental rules could pressure supply chains to tighten controls, pushing for even cleaner processes and fewer residual contaminants. Artificial intelligence and smart analytics make it easier to watch batch quality and predict shelf life or weird reactions before releasing product to patients. No matter where new science takes it, trusted old red iron oxide finds fresh ground wherever safety, reliability, and visible distinction need to meet under a microscope, inside a drug capsule, or at a hospital counter.
Red iron oxide exists everywhere, from pottery glazes to paint pigment. In pharmaceuticals, the story changes. BP, EP, and USP grades follow strict standards. These grades must be clean, tested free of heavy metals, and processed to guarantee patient safety. Tablets, capsules, ointments—every format depends on predictable behavior from its colorants. Pharmaceutical quality delivers that.
Try opening your medicine cabinet. Most colored pills and capsules contain some form of iron oxide. Red iron oxide helps manufacturers achieve an appealing, recognizable color. It means Tylenol’s caplets stand out from a vitamin C tablet, and doctors and patients can avoid mix-ups. In my experience, visiting a compounding pharmacist reveals just how much effort goes into making medication visually distinctive. These colorants don’t just serve aesthetics; they act as tools for safety and trust.
Red iron oxide proves valuable across products. Many creams and ointments use it as a coloring agent. In these cases, it isn’t only about looks. Soft pastes, gels, and powders become easier to dose, divide, and handle. Pharmacists can see when a mixture stays homogenous, catching errors before anyone is put at risk. Precise coloring can help users measure and apply topical products, or spot contamination.
Counterfeit drugs undermine health care everywhere. Red iron oxide’s role in a pill’s appearance helps patients spot fakes. Strict control over source and purity makes pharma-grade iron oxide less likely to introduce contaminants like lead or arsenic, which can turn up in cheaper, less controlled pigment sources. The international standards (BP, EP, USP) carry the heavy lift, providing a baseline patients and healthcare staff can count on. Finished products pass many rounds of quality checks, and red iron oxide must pass each one, every time.
Red iron oxide isn’t perfect. Some people have allergies, though rare, and any additive brings its own risk. Ingredient transparency goes a long way here. Every tablet, cream, or capsule should clearly list colorants. Regulators in Europe and America demand this on labels, responding to years of patient feedback. Better traceability means less room for mistakes or hidden hazards.
There’s another reality: the environmental burden of producing pigments. Traditionally, mining and refining run-ups pollution and waste. In response, research and pharmaceutical manufacturers now look for greener methods. A big shift comes from synthetic production, which creates fewer contaminants and allows precision on particle size and shade. This change, while not perfect, shows how tighter controls and responsible manufacturing keep both people and the planet healthier.
Manufacturers can push for stricter supplier audits and full traceability, making sure every batch originates from certified sources and upholds safety at every stage. Including allergy reporting tools for consumers gives patients a clearer voice. Medical professionals, too, should talk openly about medication additives—not just their active ingredients. Finally, ongoing investment in clean production methods helps shrink the ecological footprint. These actions support trust, safety, and sustainability in a world that counts on pills doing their job—right down to the color.
Red iron oxide finds its place in several pharmaceutical products as a colorant. Tablets, capsules, and occasionally topical creams carry its distinct shade. This ingredient offers more than just color—it helps patients and pharmacists distinguish between medicines. In my experience, small details like color help avoid mistakes, especially in busy clinics where pill confusion causes real danger.
Manufacturers use red iron oxide labeled BP, EP, and USP grade. These labels matter: BP means it meets the British Pharmacopoeia, EP stands for European Pharmacopoeia, and USP identifies it as United States Pharmacopeia standard. Each of these standards demands proof of purity, precise manufacturing controls, and strong oversight against contaminants. Contaminants—like heavy metals or unreacted chemicals—can spell disaster if left unchecked. A label alone isn’t enough, though. Manufacturers and regulators must ensure real-world batch testing, not just paperwork, protects patient safety.
Red iron oxide used at pharma grade gets processed, tested, and supplied to meet strict safety regulations—unlike grades made for construction or art. The U.S. Food and Drug Administration (FDA) approves iron oxides as color additives for specific uses in drugs and cosmetics. The agency sets daily intake limits and enforces heavy metal controls. In Europe, the European Medicines Agency uses similar safety guidelines.
Some people worry about metals in colorants. Rightfully so: raw or industrial-grade red iron oxide sometimes contains levels of lead, arsenic, or mercury that could harm health with long exposure. Pharma-grade versions must clear tight limits—usually below one part per million. Third-party labs run the tests, and reputations ride on honest reporting. Getting caught with substandard additives could mean costly recalls or permanent damage to trust.
Despite tough rules, supply chain problems crop up. Low-quality suppliers sometimes slip their products into the chain, and once they end up in drugs, tracing the problem can get complicated. In my work with quality teams, supply audits catch most fraud, but not every company checks with the same rigor. Medical staff face enough risks. Red iron oxide’s grade must never add to their burden.
The safest course is only working with well-established suppliers. Documented, consistent lab results help. Regular testing of every batch, not just spot checks, closes loopholes. Real accountability starts at the source, not when the finished pill lands in a hospital pharmacy. I’ve seen pharmacists demand supplier audits after rumors about suspect batches—and that vigilance keeps public health as the top concern.
Technology can help crack down on contaminated ingredients. Some companies bring in blockchain tracking, others tighten import inspections. Still, personal relationships—buyers who know their suppliers and demand regular updates—set the gold standard. Protecting patients means putting these checks ahead of cutting costs or hurrying production. Over my years in the field, companies that go beyond the minimum see fewer recalls and more loyalty from healthcare professionals.
Used with care, pharma-grade red iron oxide plays a useful and safe role in medicine. Backed by transparent sourcing, high standards, and tough testing, it helps drugmakers deliver safe products that look as reliable as the science behind them. Focusing on these details keeps the public’s trust, and keeps medicines as safe as they look.
Pharmaceutical manufacturing runs on tight specifications, both for quality and for patient safety. Red iron oxide, labeled as BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) Pharma Grade, often goes into medicinal tablets, capsules, and topical products. The bright color gives clear differentiation, but safety rests on the purity and content standards set by these pharmacopeias.
Only iron oxide with a high purity level meets the pharmaceutical line. For BP, EP, and USP grades, manufacturers need to see purity above 95%, usually around 97–99%. Lower purity red iron oxide can hide contaminants or harmful trace metals which regulators and drug makers can’t accept.
Iron content forms the backbone of these powders. USP and EP specify that Fe2O3—the chemical formula for iron(III) oxide—should be present within a narrow percentage by weight, often between 96% and 101%. This tight window blocks dilution and adulteration.
Heavy metal contamination gets close scrutiny in every pharmaceutical ingredient. In BP, EP, and USP standards alike, the total heavy metals (measured as lead) should fall below 20 ppm (parts per million). For arsenic, the usual upper limit sits at 2 ppm. Failing to screen for these metals could endanger patients, especially the immune-compromised.
In my quality control experience, any batch with heavy metals above these defined levels never reaches the production floor. Pharmaceutical industry recalls trace levels of mercury, lead, and cadmium from old pigment sources—a mistake no one wants to repeat.
Colorants for medicine must also avoid biological contamination. Microbial testing means checking for pathogens: bacteria, yeast, mold, and sometimes specific bugs like Salmonella or E. coli. Passing standards show less than 100 colony-forming units (CFU) per gram for total aerobic microbial count and less than 100 CFU/g for total yeast and molds. Salmonella or Escherichia coli must not be detected in a prescribed test amount. Clean handling and sealed packaging across the supply chain help guard against invisible threats.
Red iron oxide needs to resist dissolution; if it bleeds or dissolves in product, the color doesn’t stay put. Pharmaceutical specifications check for solubility in water and acid: only insoluble forms pass through. Some grades call for pH tests of aqueous extractions, keeping values neutral to slightly alkaline to support stability.
Loss on drying—how much water evaporates from a measured weight—gets capped around 1% for BP, EP, and USP grades. Extra moisture can mean product spoilage, so it stays low.
Counterfeit and poorly refined ingredients can break the supply chain. Trustworthy producers constantly verify raw materials using instruments like atomic absorption spectrometers for heavy metals and infrared spectrometry for chemical ID. As new suppliers enter the market, many established firms invest in site audits or even in-house re-testing.
Global trends now ask for even tighter standards. Upcoming versions of BP, EP, and USP point to better testing for nanoparticles, new forms of contamination, and consistent batches. Patients count on medications that perform as they should—and those pills get their color from high-quality, scrutinized red iron oxide.
Red Iron Oxide in its pharma grade form, like BP, EP, or USP, plays an important role in products people rely on daily—from tablets to creams. Nobody wants a contaminated batch or product that breaks down early. I’ve spent years dealing with storage headaches in labs and seen firsthand how a little care goes a long way. This pigment stays stable as long as you treat it right. Put it anywhere damp or hot, and you risk clumping, caking, or even contamination. Moisture is the enemy here—not just because it leads to lumps, but because it can invite unexpected reactions or even support microbial growth.
Let it sit in a humid room, and you’ll see changes happen fast. Pharma standards require that active and inactive ingredients keep their structure and purity from the warehouse to the production line. If humidity creeps above 60%, or if temperature swings wildly, purity doesn’t stick around. Keep red iron oxide in a cool, dry place. Ideally, shoot for storage between 15°C and 25°C, with humidity locked down below 50%. A temperature-controlled storage area with good airflow does more for stability than any fancy packaging can make up for.
Every time someone cuts corners with containers, they open the door to problems. Use airtight, sealed containers made from food-safe plastic or glass. Anything less, and dust, bugs, or fumes from other chemicals might get in. Metal containers can seem solid, but iron compounds react with some metals, so it’s smarter to use something inert. During a visit to a small compounding facility, I once saw what looked like rust on stored product—turns out, some of the iron oxide had reacted with an old metal drum lid. Avoiding these mishaps protects both your resources and the end user.
Always label containers with the full product name, grade, lot number, and date of receipt. Sounds simple, but confusion over unlabeled containers has caused more than one recall. Store red iron oxide away from acids, alkalis, and anything volatile because cross-contamination or chemical interaction can ruin a lot fast. Position products off the ground, on clean shelves, and separated by type. I’ve walked into facilities where powders were stacked on dirty floors or shoved into corners; that’s an open invitation for spillage and accidental mixing.
No storage system works if people aren’t on board. Everyone handling pharma-grade pigment needs training—not just on where stuff goes, but why conditions matter. Annual audits seem tedious, but they spot trouble before it can become a safety issue. Set routines for checking seals, inspecting for water damage, and logging temperature and humidity. Not every mishap leaves a mark you can see. Routine checks pick up on the subtle stuff, like slowly rising moisture levels, that might otherwise slip by.
Good storage doesn’t demand expensive equipment. Use dehumidifiers in damp climates. Check if your area heats up on sunny afternoons, as even a few hours of high temperatures can degrade quality. Simple silica gel packets in each drum can keep moisture out long-term. Most importantly, keep clear records of inspections and environmental conditions for every batch, so any suspected problem can get traced back fast. Pharmacy and manufacturing rely on keeping things safe and stable; that starts with storage done right.
Red iron oxide appears everywhere in pharmaceutical products. Its deep color shows up in tablet coatings, pills, and even some cosmetics. People often overlook the material behind the red. But in medicine, this ingredient can't just be any red pigment. Medicines go into the body, so every input deserves scrutiny. Regulations step in here, shaping what is safe. The world’s major pharmacopeias—the British Pharmacopoeia (BP), the European Pharmacopoeia (EP), and the United States Pharmacopeia (USP)—set a clear standard for quality. If you’re in the business or you take medicines, standards directly affect your health and trust.
Red iron oxide labeled as BP, EP, or USP pharma grade isn’t a marketing term. It signals a product checked and tested to meet the strictest pharmacopeia rules. This covers everything from purity and ingredient limitations to how the powder looks. Here’s the reality: pharma standards do not just shield against sickness—they also fight against unpredictable side effects and product recalls. I’ve seen suppliers try to tempt labs with cheaper alternatives, pushing generic red iron oxide that slides past these benchmarks. Those versions sometimes show up with extra metals, dirt, or weird particles. Regulators know what to look for, and their rules catch tiny contaminants others miss.
The USP, BP, and EP break down their standard requirements right in the published monographs. These books call for tests on everything from particle size to trace heavy metals like lead or arsenic. For instance, the iron percentage can’t dip or jump, because that affects coating performance and, possibly, patient safety. I've worked with labs that ran tests on “pharma grade” from new suppliers, only to find off-the-chart lead or changes in color strength. Without compliance, a supply chain can send medicines back to square one, wasting millions as batches get dumped.
Pharmaceutical companies who skip formal testing risk more than financial loss. They gamble with approvals from drug regulators. A red iron oxide batch missing BP, EP, or USP certification lands companies in trouble with agencies like the FDA or EMA. Once, I watched a small pharmaceutical company grind to a halt because its colorant failed to meet the USP’s tests for heavy metals. Their customers, from big cities to rural clinics, waited weeks for those drugs to return. The impact of such delays hits the end user hardest—the patient waiting for a routine prescription refill.
Getting pharma grade red iron oxide to pass global benchmarks doesn’t just happen. It takes regular, updated testing by the producer. Labs run repeated assays, train staff, and audit every batch. Sometimes, powder travels across borders. Importers have to match the receiving country’s pharmacopeia rules, not just the exporter’s. Keeping up with new research on contaminants, or changes in allowable limits, becomes an ongoing challenge for every firm in the chain. Customers need batch documentation and certificates to confirm everything lines up with the book. Open conversations with suppliers—supported by real lab data—make a big difference. Instead of just trusting the label, buyers can review certificates and batch records to make informed, safe decisions.
Manufacturers should work closely with accredited labs experienced in pharmacopeia compliance. Companies investing in transparent quality reporting cut down risks before problems land in the hands of the public. As someone who’s seen both sides—production and point-of-care—clear communication bridges the gap between technical documents and safe, effective medicine. Stakeholders should push for supplier audits, continued staff training, and shared information if pharmacopeia standards shift. For every batch of red iron oxide that checks all the boxes, trust in medicine builds, one pill at a time.
| Names | |
| Preferred IUPAC name | iron(III) oxide |
| Other names |
Ferric Oxide Iron(III) Oxide Fe2O3 Red Oxide of Iron Colcothar Iron Sesquioxide |
| Pronunciation | /ˈrɛd ˈaɪərn aɪˈɒksaɪd ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑːrmə ˈɡreɪd/ |
| Identifiers | |
| CAS Number | 1309-37-1 |
| Beilstein Reference | 1309-37-1 |
| ChEBI | CHEBI:50844 |
| ChEMBL | CHEMBL1201591 |
| ChemSpider | 14133 |
| DrugBank | DB13249 |
| ECHA InfoCard | ECHA InfoCard: 100.013.680 |
| EC Number | 215-168-2 |
| Gmelin Reference | 137 |
| KEGG | C177701 |
| MeSH | D015537 |
| PubChem CID | 518696 |
| RTECS number | UNN379F7N7 |
| UNII | J0G6M8G6K5 |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | CompTox Dashboard (EPA)": "DTXSID8023575 |
| Properties | |
| Chemical formula | Fe2O3 |
| Molar mass | 159.69 g/mol |
| Appearance | Reddish-brown fine powder |
| Odor | Odorless |
| Density | 5.12 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 2.18 |
| Acidity (pKa) | 14.0 |
| Basicity (pKb) | “11.74” |
| Magnetic susceptibility (χ) | '0.5 × 10^-6 cm³/mol' |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 87.4 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -824.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -824 kJ/mol |
| Pharmacology | |
| ATC code | V03AB37 |
| Hazards | |
| Main hazards | May cause respiratory irritation. May cause eye and skin irritation. |
| GHS labelling | GHS07, GHS08, Warning, H332, H335, H373, P261, P271, P304+P340, P312, P403 |
| Pictograms | GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. |
| Precautionary statements | Precautionary statements: P261, P264, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | NFPA 704: 1-0-0 |
| Lethal dose or concentration | LD50 (oral, rat): >5000 mg/kg |
| LD50 (median dose) | > 10,000 mg/kg (oral, rat) |
| NIOSH | NIOSH: NV 0500000 |
| PEL (Permissible) | 5 mg/m3 |
| REL (Recommended) | 200 mg/kg |
| IDLH (Immediate danger) | 2500 mg Fe/m³ |
| Related compounds | |
| Related compounds |
Yellow Iron Oxide Black Iron Oxide Brown Iron Oxide Iron(III) Oxide Iron(II) Oxide Ferric Oxide Synthetic Red Iron Oxide |
Chengguan District, Lanzhou, Gansu, China
